APOE and Alzheimer disease: Prior studies have demonstrated that apoE disrupts Aβ clearance across the mouse BBB [39], specifically, apoE4, which carries major genetic risk for AD [40–42], had greater disruptive effect than apoE3, which carries lower risk.